Helix Nanotechnologies
Next-generation mRNA platform to solve cancer, COVID and climate.
Y CombinatorWinter 2017ActiveHealthcareDrug Discovery and DeliveryArtificial IntelligenceBiotechGenomicsNanotechnology
What they do
Problem
Developing and deploying effective biological treatments and engineered solutions is slow, expensive, and centralized, limiting progress against diseases like cancer and COVID and other biological challenges.
Solution
A next-generation mRNA platform that improves mRNA design and experimentation to rapidly create and deliver biological therapies and products at much lower cost.
Who it's for
Biotech and pharmaceutical R&D teams and researchers developing mRNA-based therapeutics and bioengineered products.
Founders
Nikolai Eroshenko
Founder/CSO
Company timeline
- YC batchWinter 2017
- StatusActive
- Team size22 people
- LocationBoston, MA, USA; Cambridge, MA, USA
Similar startups
Quince Therapeutics
Quince TherapeuticsQuince Therapeutics (fka Cortexyme) is a late-stag…
Entelexo Biotherapeutics
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
Pardes Biosciences
We break viruses
FinalDose
Programmable DNA drug destroying all cancers, unlocking 80% of targets
Kernal Biologics
Kernal is creating mRNA 2.0 therapies that work in specific cells
Ochre Bio
RNA medicines for liver diseases